Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Fahey CG"'
Autor:
Moye AL; Stem Cell Program and Divisions of Hematology/Oncology and Pulmonary Medicine, Boston Children's Hospital, Boston, MA, USA.; Harvard Stem Cell Institute, Cambridge, MA, USA.; Department of Genetics, Harvard Medical School, Boston, MA, USA., Dost AF; Stem Cell Program and Divisions of Hematology/Oncology and Pulmonary Medicine, Boston Children's Hospital, Boston, MA, USA.; Harvard Stem Cell Institute, Cambridge, MA, USA.; Department of Genetics, Harvard Medical School, Boston, MA, USA.; Hubrecht Institute, Oncode Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), Utrecht, The Netherlands., Ietswaart R; Department of Genetics, Harvard Medical School, Boston, MA, USA., Sengupta S; Stem Cell Program and Divisions of Hematology/Oncology and Pulmonary Medicine, Boston Children's Hospital, Boston, MA, USA.; Harvard Stem Cell Institute, Cambridge, MA, USA.; Department of Genetics, Harvard Medical School, Boston, MA, USA., Ya V; Stem Cell Program and Divisions of Hematology/Oncology and Pulmonary Medicine, Boston Children's Hospital, Boston, MA, USA.; Harvard Stem Cell Institute, Cambridge, MA, USA.; Department of Genetics, Harvard Medical School, Boston, MA, USA., Aluya C; Stem Cell Program and Divisions of Hematology/Oncology and Pulmonary Medicine, Boston Children's Hospital, Boston, MA, USA.; Harvard Stem Cell Institute, Cambridge, MA, USA.; Department of Genetics, Harvard Medical School, Boston, MA, USA., Fahey CG; Stem Cell Program and Divisions of Hematology/Oncology and Pulmonary Medicine, Boston Children's Hospital, Boston, MA, USA.; Harvard Stem Cell Institute, Cambridge, MA, USA.; Department of Genetics, Harvard Medical School, Boston, MA, USA.; Harvard University and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Louie SM; Stem Cell Program and Divisions of Hematology/Oncology and Pulmonary Medicine, Boston Children's Hospital, Boston, MA, USA.; Harvard Stem Cell Institute, Cambridge, MA, USA.; Department of Genetics, Harvard Medical School, Boston, MA, USA., Paschini M; Stem Cell Program and Divisions of Hematology/Oncology and Pulmonary Medicine, Boston Children's Hospital, Boston, MA, USA.; Harvard Stem Cell Institute, Cambridge, MA, USA.; Department of Genetics, Harvard Medical School, Boston, MA, USA., Kim CF; Stem Cell Program and Divisions of Hematology/Oncology and Pulmonary Medicine, Boston Children's Hospital, Boston, MA, USA. carla.kim@childrens.harvard.edu.; Harvard Stem Cell Institute, Cambridge, MA, USA. carla.kim@childrens.harvard.edu.; Department of Genetics, Harvard Medical School, Boston, MA, USA. carla.kim@childrens.harvard.edu.
Publikováno v:
The EMBO journal [EMBO J] 2024 Jul; Vol. 43 (14), pp. 2843-2861. Date of Electronic Publication: 2024 May 16.
TREX1 Inactivation Unleashes Cancer Cell STING-Interferon Signaling and Promotes Antitumor Immunity.
Autor:
Tani T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mathsyaraja H; Gilead Sciences, Foster City, California., Campisi M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Li ZH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Haratani K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Fahey CG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Ota K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mahadevan NR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Shi Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Saito S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mizuno K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Thai TC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Sasaki N; Department of Cell Biology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Homme M; Department of Cell Biology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Yusuf CFB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Kashishian A; Gilead Sciences, Foster City, California., Panchal J; Gilead Sciences, Foster City, California., Wang M; Gilead Sciences, Foster City, California., Wolf BJ; Gilead Sciences, Foster City, California., Barbie TU; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Paweletz CP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Gokhale PC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Uppaluri R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Kitajima S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Cell Biology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Cain J; Gilead Sciences, Foster City, California., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 May 01; Vol. 14 (5), pp. 752-765.
Autor:
Gupta M; Stem Cell Program, Division of Hematology/Oncology and Division of Pulmonary Medicine, Boston Children's Hospital, Boston, Massachusetts.; Department of Genetics, Harvard Medical School, Boston, Massachusetts.; Biological and Biomedical Sciences PhD Program, Harvard University, Boston, Massachusetts., Concepcion CP; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts., Fahey CG; Stem Cell Program, Division of Hematology/Oncology and Division of Pulmonary Medicine, Boston Children's Hospital, Boston, Massachusetts.; Department of Genetics, Harvard Medical School, Boston, Massachusetts., Keshishian H; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Bhutkar A; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts., Brainson CF; Markey Cancer Center, University of Kentucky, Lexington, Kentucky.; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky., Sanchez-Rivera FJ; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York., Pessina P; Stem Cell Program, Division of Hematology/Oncology and Division of Pulmonary Medicine, Boston Children's Hospital, Boston, Massachusetts.; Department of Genetics, Harvard Medical School, Boston, Massachusetts., Kim JY; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts., Simoneau A; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Paschini M; Stem Cell Program, Division of Hematology/Oncology and Division of Pulmonary Medicine, Boston Children's Hospital, Boston, Massachusetts.; Department of Genetics, Harvard Medical School, Boston, Massachusetts., Beytagh MC; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts., Stanclift CR; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Schenone M; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Mani DR; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Li C; Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital Harvard Medical School, Boston, Massachusetts., Oh A; Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital Harvard Medical School, Boston, Massachusetts., Li F; Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, New York., Hu H; Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, New York., Karatza A; Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, New York., Bronson RT; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts., Shaw AT; Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital Harvard Medical School, Boston, Massachusetts., Hata AN; Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital Harvard Medical School, Boston, Massachusetts., Wong KK; Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, New York., Zou L; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Carr SA; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Jacks T; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Howard Hughes Medical Institute, Cambridge, Massachusetts., Kim CF; Stem Cell Program, Division of Hematology/Oncology and Division of Pulmonary Medicine, Boston Children's Hospital, Boston, Massachusetts. carla.kim@childrens.harvard.edu.; Department of Genetics, Harvard Medical School, Boston, Massachusetts.; Harvard Stem Cell Institute, Cambridge, Massachusetts.
Publikováno v:
Cancer research [Cancer Res] 2020 Sep 15; Vol. 80 (18), pp. 3841-3854. Date of Electronic Publication: 2020 Jul 20.